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ABSTRACT
Background: Ocular melanoma is very rare compared to cutaneous melanoma in horses. Definitive diagnosis is made 
through histopathological examination and treatment options include surgical excision associated with cryotherapy, radia-
tion therapy, and chemotherapy. In this report, we describe a case of conjunctival melanoma in a horse that has been treated 
successfully with surgical excision associated with cryotherapy.
Case: A 15-year-old male Percheron male was referred to the Ophthalmology Veterinary Section of the Federal University 
of Rio Grande do Sul (UFRGS), Porto Alegre, Brazil, with a history of a pigmented mass located on the lower eyelid of 
the left eye. Ophthalmologic examination revealed ocular discomfort, secretion and a pigmented mass in the left inferior 
bulbar conjunctiva. The dermatological examination revealed other melanomas in the perineal region. Complete blood 
count and serum chemistry profile were within normal ranges and prior to surgery the horse was treated with flunixin 
meglumine (1.1 mg/kg, IV, q 12 h). Sedation was performed with xylazine (0.4 mg/kg, IV) and detomidine hydrochloride 
(0.01 mg/kg, IV) and then the animal was placed in a retention trunk. The conjunctival mass was resected with a margin 
of safety. Liquid nitrogen was applied to the tumor site and the adjacent conjunctiva with a copper cryoprobe with one 
unit of liquid nitrogen. Histopathological examination revealed neoplastic cells containing pigmented melanocytes in the 
conjunctival submucosa, confirming the diagnosis of conjunctival melanoma. Postoperative treatment was performed with 
flunixin meglumine (1.1 mg/kg, IV, q 12 h) for 3 days and topical ophthalmic ointment containing neomycin, polymyxin 
B sulfate and dexamethasone twice daily for one week. Seven days after surgery, the lesion was healed. The patient was 
followed for 24 months after excision and there was no evidence of recurrence.
Discussion: Older horses are considered more predisposed to melanoma development, possibly because of the proliferation 
of melanocytes as a manifestation of aging, and in addition, cutaneous melanomas are common in gray horses and rare in 
other horse colors. In this case, the horse was a 15-year-old Percheron horse with gray hair. In horses, there is only one 
case of conjunctival melanoma documented in the literature. In both cases, the ophthalmic examination revealed a large, 
raised, heavily pigmented mass protruding from the bulbar conjunctiva. The only difference is that in the present case the 
location of the mass was in the inferior bulbar conjunctiva and in the case cited in the literature. The mass was located in 
the bulbar conjunctiva under the lateral comer. In this case, the diagnosis of conjunctive melanoma was based on clinical 
signs and confirmed by histopathological examination. It was decided to perform an excisional biopsy for treatment and to 
confirm the diagnosis of conjunctival melanoma. The choice of treatment depends very much on the clinical presentation, 
that in this animal, despite the neoplasia being extended, it was located only in the conjunctiva without involvement of 
the sclera and the eyelid. Therefore the decision was made to perform an excisional biopsy associated with cryotherapy. 
The purpose of such adjuvant therapy is to kill all residual tumor cells and prevent the recurrence of malignant tumors. In 
the present case, the surgical wound was cured one week after surgery. The surgical procedure in the case reported was 
performed under local anesthesia and sedation with the horse standing. To make this decision, consideration should be 
given to patient health, anesthetic risk, and additional risks during recovery from general anesthesia. In this case, surgi-
cal excision of the mass associated with cryotherapy was effective in the treatment of conjunctival melanoma in a horse.
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INTRODUCTION
Cutaneous melanoma is highly prevalent in 
horses. These tumors are found most frequently in the 
perineal area, the external genitalia, the ventral surface 
of the tail and the parotid region [10]. Melanomas occur 
frequently in grey horses after the age of 5 years [1]. 
Ocular melanomas are uncommon in comparison to 
cutaneous tumors in horses [6]. The definitive diagno-
sis of melanomas requires a microscopic examination 
of biopsy specimens. In humans, treatment options 
for conjunctival melanoma include surgical excision, 
excision associated with cryotherapy, radiotherapy, 
and chemotherapy [2]. Melanomas located in the or-
bit, ocular adnexa, epibulbar area, or intraocular have 
been reported in horses [1,5]. However, a review of 
the literature reveals only a single documented case 
of melanoma located in the conjunctiva of a horse [6]. 
This report describes a case of melanoma involving the 
lower bulbar conjunctiva of a horse successfully treated 
with surgical excision associated with cryotherapy. 
CASE 
 A 15-year-old male grey Percheron horse was 
referred to the Ophthalmology Veterinary Section of 
the Federal University of Rio Grande do Sul (UFRGS), 
Porto Alegre, Brazil, was referred for the evaluation 
of a pigmented mass located on the lower eyelid of 
his left eye. The horse owner reported that the mass 
had been present for approximately two years but had 
recently increased in size. Upon clinical examination, 
the horse was with an optimum body condition score. 
An ophthalmic examination revealed blepharospasm, 
epiphora, ocular discharge, and a mass with 3 cm in 
diameter on the bulbar conjunctiva of the left eye (Fig-
ure 1A). Direct and consensual pupillary light reflex, 
palpebral reflex, menace response, and dazzle reflex 
were normal in both eyes. In addition, the remainder 
of the ophthalmic examination of the left eye was 
unremarkable. The right eye was normal. A dermato-
logical examination revealed other melanomas in the 
perineal region. 
Complete blood count and serum chemistry 
profile were within normal ranges. Surgical exci-
sion followed by cryotherapy and histopathological 
examination of the mass was recommended. Prior to 
surgery, the horse was treated with flunixin meglumine 
(Banamine injetável)1 [1.1 mg/kg, IV, q 12 h]. The 
horse was sedated with xylazine (Sedomin)2 [0.4 mg/
kg, IV)], and detomidine hydrochloride (Dormium V)3 
[0.01 mg/kg, IV], and then placed in a restraint trunk. 
The surgical area was routinely prepared for 
aseptic surgery and the mass was exteriorized with two 
hemostatic forceps (Figure 1B). After instillation of 
topical anesthetic drops, lidocaine hydrochloride was 
infiltrated into the conjunctiva around the operation 
site. The conjunctival mass was totally resected with a 
safety margin. There is no involvement of the palpebral 
conjunctiva. Liquid nitrogen was applied to the tumor 
site and adjacent conjunctiva with a copper cryoprobe 
attachment with a liquid nitrogen unit4. Liquid nitrogen 
was used in two cycles of 10 s of freezing.  The resec-
ted tissue was placed in 10% buffered formalin and 
submitted for histological examination in the Sector of 
Veterinary Pathology (SVP), Faculdade de Veterinária 
(FaVet), Universidade Federal do Rio Grande do Sul 
(UFRGS), Porto Alegre, RS, Brazil. 
Postoperative treatment consisted of flunixin 
meglumine (1.1 mg/kg IV, q12 h) for 3 days and 
topical ophthalmic ointment containing neomycin, 
polymyxin B sulfate and dexamethasone twice daily 
for one week. No intraoperative complications occur-
red during the procedure. Minimal hemorrhaging was 
observed during the dissection of the mass. On the first 
day after surgery, the horse showed no signs of ocular 
discomfort. After one week, the horse was re-evaluated, 
revealing healing of the lesion. Histologically, the 
lesion was heavily pigmented with neoplastic cells 
containing pigmented melanocytes in the conjunctival 
submucosa (Figure 1C). Periodic evaluations were 
performed and there was no evidence of neoplasm 
recurrence 24 months post-surgery (Figure 1D). 
DISCUSSION
Cutaneous melanomas are common in grey 
horses and rare in other colors of horses [10]. Older 
horses are predisposed to the development of mela-
noma, possibly because of the proliferation of mela-
nocytes as a manifestation of aging [10]. In this case, 
the horse was a 15-year-old Percheron horse with gray 
hair. Conjunctival melanomas are not reported frequen-
tly in humans and other animals [3,7-9,11]. In horses, 
there is only a single case of conjunctival melanoma 
documented in the literature [6]. 
The clinical presentation of melanoma in the 
present case was similar to that described in the previou-
sly reported case. In both cases, the ophthalmic exami-
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nation revealed a large, raised, heavily pigmented mass 
protruding from the bulbar conjunctiva. The difference 
is that, in the case cited by Moore and collaborators, 
the mass was localized in the bulbar conjunctiva under 
the lateral canthus, while in the present case report, the 
mass was localized in the lower bulbar conjunctiva. 
The diagnosis of conjunctival melanoma in 
the present case was based on the clinical signs and 
confirmed by histopathology. In humans, it has been 
recommended that, if possible, conjunctival neoplasias 
should be managed using a no-touch technique by wide 
microsurgical excisional biopsy, and cryotherapy [3,7]. 
An incisional biopsy should be avoided to reduce the risk 
of tumor dissemination and possible recurrence. In this 
case, it was decided excisional biopsy for treatment and 
to confirm the diagnosis of conjunctival melanoma. The 
primary therapeutic approach to this tumor is extremely 
important, because incomplete removal is followed by 
tumor recurrence and distant metastasis [3,11]. 
The choice of treatment for malignant me-
lanoma of the conjunctiva depends mainly on the 
clinical presentation. In the present case, despite the 
neoplasia being extended, it was located only in the 
conjunctiva without involvement of the sclera and 
eyelid. For this reason, the decision was made to 
perform an excisional biopsy associated with cryothe-
rapy. Reports of the treatment of adnexal melanomas 
in horses are rare [1,6]. In the treatment of melanoma 
located on the human conjunctiva, the gold standard 
is wide surgical excision and cryotherapy to the mar-
gins [2,3]. In most cases, melanocytic neoplasms are 
susceptible to cryotherapy [2]. 
The goal of adjuvant therapy is to kill any 
residual tumor cells and prevent the recurrence of 
malignant tumors [11]. Complications associated 
with cryotherapy include cataracts, uveitis, scleral and 
corneal thinning, and phthisis bulbi [2]. In the present 
case, postoperative complications were not observed 
and the surgical wound was healed one week after 
Figure 1. Conjunctival melanoma in a horse. A- Darkly pigmented mass at the lower in lower bulbar conjunctiva. B- The tumor was exposed with two 
clamps. C- Histologic section showing conjunctiva well delimited. Neoplastic cells containing pigmented melanocytes in the submucosa. D- Appearence 
of the left eye two years after surgery. The horses left eye does not show any sign of tumor regrowth.
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surgery. In cases where the conjunctival melanoma 
is more extensive, exenteration of the eyeball may 
be required [6].
 In the case reported here, the surgical procedu-
re was performed with the horse in station. The decision 
to perform the procedure in a standing patient rather 
than under general anesthesia depends on many factors, 
such as patient health, anesthetic risk, and additional 
risks during recovery from general anesthesia [4]. With 
this anesthetic protocol, it was possible to perform the 
procedure without complications. There are no publi-
cations in the literature comparing surgical treatment 
alone with surgical excision associated with adjacent 
therapies such as cryotherapy in horses, making it di-
fficult to draw comparisons. A single report of primary 
malignant melanoma responded well to exenteration 
following failed attempts at local excision combined 
with cryosurgery in a horse [6]. 
The findings indicate that melanoma must 
be considered in the differential diagnosis of the ne-
oplasm that affects the conjunctiva in horses. In the 
present case, surgical excision of the mass associated 
with cryotherapy was effective in the treatment of a 
conjunctival melanoma in a horse.
MANUFACTURERS
1MSD Saúde Animal. São Paulo, SP, Brazil.  
2König do Brasil. Mairinque, SP, Brazil.  
3Agener União - Saúde Animal. São Paulo, SP, Brazil.  
4Brymill Cryogenic Systems. Ellington, CT, USA.
Declaration of interest. The authors report no conflicts of 
interest. The authors alone are responsible for the content and 
writing of the paper.
REFERENCES
1 Albanese V., Newton J.C. & Waguespack R.W. 2013. Malignant melanoma of the third eyelid in a horse. Equine 
Veterinary Education. 6(7): 15-19. 
2 Cagini C., Menduno P. & Ignagni S. 1996. Combined surgery and cryotherapy for melanoma of the conjunctiva: 37 
months’ follow-up. European Journal of Ophthalmology. 6(3): 343-345. 
3 De Potter P., Shields C.L., Shields J.A. & Menduke H. 1993. Clinical predictive factors for development of recurrence 
and metastasis in conjunctival melanoma: a review of 68 cases. British Journal of Ophthalmology. 77(10): 624-630. 
4 Hewes C.A., Keoughan G.C. & Gutierrez-Nibeyro S. 2007. Standing enucleation in the horse: A report of 5 cases. 
Canadian Veterinary Journal. 48(5): 512-514. 
5 McMullen R.J., Clode A.B., Pandiri A.K.R., Malarkey D.E., Michau T.M. & Gilger, B.C. 2008. Epibulbar mela-
noma in a foal. Veterinary Ophthalmology. 11(1): 44-50. 
6 Moore C.P., Collins B.K., Linton L.L. & Collier L.L. 2000. Conjunctival malignant melanoma in a horse. Veterinary 
Ophthalmology. 3(2-3): 201-206. 
7 Paridaens A.D., Minassian D.C., McCartney A.C. & Hungerford J.L. 1994. Prognostic factors in primary malig-
nant melanoma of the conjunctiva: a clinicopathological study of 256 cases. British Journal of Ophthalmology. 78(4): 
252-259. 
8 Payen G., Estrada M., Clerc B. & Chahory S. 2008. A case of conjunctival melanoma in a cat. Veterinary Ophthal-
mology. 11(6): 401-405. 
9 Schobert C.S., Labelle P. & Dubielzig R.R. 2010. Feline conjunctival melanoma: histopathological characteristics 
and clinical outcomes. Veterinary Ophthalmology. 13(1): 43-46. 
10 Seltenhammer M.H., Simhofer H., Scherzer S., Zechner R., Curik I., Sölkner J., Brandt S.M., Jansen B., Pe-
hamberger H. & Eisenmenger E. 2003.  Equine melanoma in a population of 296 grey Lipizzaner horses. Equine 
Veterinary Journal. 35(2): 153-157. 
11 Shields C.L., Shields J.A., Gündüz K., Cater J., Mercado G.V., Gross N. & Lally B. 2000.  Conjunctival melanoma: 
risk factors for recurrence, exenteration, metastasis, and death in 150 consecutive patients. Archives of Ophthalmol-
ogy. 118(11): 1497-1507. 
